London, 07 August 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Cytomegalovirus Retinitis Market 2014-2018, which is expected to grow at a CAGR of 4.50 percent during the forecast period of 2013-2018.
Cytomegalovirus retinitis is a viral inflammation of the retina. The disease is caused by cytomegalovirus, a herpes virus that attacks the photosensitive cells in the retina. If left untreated, the disease can lead to permanent blindness. Most people are exposed to cytomegalovirus at some point in their life, but the infection usually affects those with a weakened immune system such as HIV-positive patients.
Key Market Drivers
- Presence of Unmet Needs
- Availability of Improved Diagnostic Tool
- High Rate of Prevalence of Cytomegalovirus Retinitis
Key Market Trends
- Increase in Use of Combination Therapies
- Increase in Prophylactic Treatment
- Increasing Awareness of Cytomegalovirus Retinitis
“Cytomegalovirus retinitis can be managed by taking pre-emptive and prophylactic approaches in high-risk patients,” says Faisal Ghaus, Vice President of TechNavio.
“The dose for prophylactic treatment is lower than the doses meant for the treatment of the active disease. This is intended as a long-term therapy to protect the patients from further infections because of the cytomegalovirus.”
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
